Sixteen castrated male Large White 3 Landrace pigs were employed to investigate the muscle type-specific changes of gene expression in response to recombinant porcine growth hormone (rpGH) administration. Pigs were injected intramuscularly with rpGH (4 mg/day, n 5 8) or saline (n 5 8) for 28 days. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the mRNA abundance of genes related to muscle growth in longissimus dorsi (LD) and semitendinosus (ST) muscles. Myofibre-type composition was characterised by the ratio of the expression of myosin heavy chain (MyHC) 1, 2a or 2b relative to 2x. The results showed that the relative myofibre-type composition of neither LD nor ST was affected by rpGH administration. rpGH administration did not induce significant changes in the abundances of myostatin and myogenin mRNA in both types of muscle. MyoD and calpain 3 mRNA were significantly increased after rpGH treatment in ST muscle, whereas the difference was not significant in LD muscle. A tendency of down-regulation was observed for PGC-1a mRNA expression in ST muscle of rpGH-treated group (P 5 0.16). These results suggest that myoD, calpain 3 and probably PGC-1a may be involved in the mechanism of exogenous GH action on skeletal muscle growth; rpGH up-regulates mRNA expression of myoD and calpain 3 in a muscle type-specific manner, being more remarkable in ST than in LD, whereas no influences of rpGH on the mRNA expression of myostatin and myogenin were detected.
Introduction
The effect of exogenous growth hormone (GH) on animal growth and meat quality has been studied extensively during the last decades. It has been confirmed that exogenous GH can improve animal daily weight gain, feed efficiency and lean accretion rate (Campbell et al., 1989; Brameld et al., 1996) . The responses of hormones and genes in somatotropic axis, such as GH receptor, IGF-1 and IGF-1 receptor have also been observed closely as the major components in the pathway of GH action (Louveau and Bonneau, 1996; Klindt et al., 1998; Zhao et al., 2003) . However, the responses of genes participating in myogenesis and myofibre-type transformation in skeletal muscle have received less attention, despite the fact that skeletal muscle is one of the major targets for GH action and economically the most important part in meat animals.
The skeletal muscle myofibres in postnatal pigs can be classified into four major types, I, IIa, IIx and IIb, according to their metabolic and contractive characteristics. Type I fibres (red; slow-twitch) are the smallest, oxidative fibres with high lipid content and many mitochondria, whereas type IIb fibres (white; fast-twitch) are the largest, glycolytic fibres possessing high glycogen content and few mitochondria. Type IIa and IIx fibres are intermediate oxidative-glycolytic fibres. Generally, IIa fibres are more closely related to type I fibres and IIx fibres are more similar to IIb fibres (Hamalainen and Pette, 1993) . The longissimus dorsi (LD) and semitendinosus (ST) muscles differ in myofibretype composition. LD muscle is composed primarily of glycolytic myofibres, whereas ST muscle has different myofibre-type composition depending on anatomical location. The deep medial portion comprises largely of oxidative myofibres. The myofibre-type composition contributes greatly to both skeletal muscle growth and meat quality (Klont et al., 1998; Eggert et al., 2002; Chang et al., 2003) . Compared with its well-defined positive effect on myofibre hypertrophy, the influence of rpGH on myofibre-type composition is still under debate. Many studies reported that exogenous GH had no effect on the skeletal muscle fibre composition (Solomon et al., 1988 and 1990; Beermann et al., 1990; Czerwinski and Martin, 1994) , while some experiments -E-mail: zhao.ruqian@gmail.com demonstrated divergent results (Solomon et al., 1991 and .
Skeletal muscle growth involves both myofibre-type transformation and myofibre hypertrophy in pigs. Recently, some genes are reported to be involved in these two processes, such as myoD and myogenin (Olson, 1990; Li and Olson, 1992; Molkentin and Olson, 1996) and myostatin (Lee and McPherron, 1999; Sharma et al., 2001; Yang and Zhao, 2006) . Meanwhile, calpain 3, a member of calciumdependent protease family, acts as a skeletal musclespecific regulatory protein (Sorimachi et al., 1989 and 1990) and participates in the regulation of myofibre hypertrophy. Peroxisome proliferator-activated receptor g coactivator-1a (PGC-1a), a transcriptional coactivator expressed in several tissues including skeletal muscle, was found to activate mitochondrial biogenesis and oxidative metabolism (Knutti and Kralli, 2001 ) and was reported to drive the formation of slow-twitch muscle fibres in rodents (Lin et al., 2002) . However, data describing the responses of these genes to exogenous GH in pigs are scarce (Ji et al., 1998a and 1998b) .
Therefore, the objectives of the present study were (1) to provide an evidence of the myofibre-type composition responding to rpGH both in LD and ST muscles and (2) to clarify the responses of genes related to skeletal muscle growth at the level of transcription in LD and ST muscles upon exogenous GH administration.
Material and methods

Animals and experimental design
The experiment was undertaken following the guidelines of the regional Animal Ethics Committee. Sixteen castrated male Large White 3 Landrace pigs with average initial body weight of 50.8 kg (from 48 to 55 kg) were housed individually in floor pens and fed according to the breed standards of USA (National Research Council, 1998) . Pigs were randomly allotted to treatment or control group. The treatment group was injected intramuscularly with recombinant porcine growth hormone (rpGH, 4 mg/day) in the extensor area of the neck and the control group with vehicle at 0900 h for 28 days. Animals were slaughtered 4 h after the final injection. LD muscle adjacent to the last rib and the deep medial portion of ST muscle were taken immediately (within 5 to 10 min of death) and rapidly frozen in liquid nitrogen, and then stored at 2808C. rpGH was obtained from Shenzhen Lupeng Agricultural Hi-tech Co. Ltd, People's Republic of China.
RNA extraction and reverse transcription (RT) Total RNA was extracted from the tissue samples with a single-step method of RNA extraction by acid guanidinium thiocyanate-phenol-chloroform (Chomczynski and Sacchi, 1987 ). Total RNA concentration was then quantified by measuring the absorbance at 260 nm in a photometer (Eppendorf Biophotometer). Ratios of absorption (260/280 nm) of all preparations were between 1.8 and 2.0. Aliquots of RNA samples were subjected to electrophoresis through a 1.4% agarose-formaldehyde gel to verify their integrity.
Two micrograms of total RNA was reverse transcribed by incubation at 428C for 1 h in a 25 ml mixture consisting of 10 U avian myeloblastosis virus reverse transcriptase, 10 U RNase inhibitor, 12 mmol/l random primers, 50 mmol/l Tris-HCl (pH 8.3), 10 mmol/l MgCl 2 , 50 mmol/l KCl, 10 mmol/l DDT, 0.5 mmol/l spermidine and 0.8 mmol/l each dNTP. The reaction was terminated by heating at 958C for 5 min and quickly cooling on ice.
The expression of myosin heavy chain (MyHC) isoforms A multiplex PCR procedure reported by Tanabe et al. (1999) was followed to determine the relative expressions of MyHC isoforms in the muscle of pigs, employing four sense primers specific for MyHC (MyHC I: 5 0 -AGCCTCTTTCTTCTC CCAGGGACATTC-3 0 ; MyHC 2a: 5 0 -CACTTGCTAAGAGGGAC CTCTGAGTTCA-3 0 ; MyHC 2b: 5 0 -CATCTGGTAACATAAGAGG TACATCTAG-3 0 ; MyHC 2x: 5 0 -CTTTCCTCATAAAGCTTCAAG TTCTGCC-3 0 ) and a common anti-sense primer (5 0 -ATCC AGGCTGCGTAACGCTCTTTGAGGTTGTA-3 0 ) used in that publication. MyHC 1, 2a and 2b were respectively amplified together with MyHC 2x in the same PCR reaction.
The expression of myosatin, myogenin, myoD, calpain 3 and PGC-1a mRNA Two microlitres of RT reaction mix was used for PCR in a final volume of 25 ml containing 0.5 U Taq DNA polymerase, 5 mmol/l Tris-HCl (pH 9.0), 10 mmol/l NaCl, 0.1 mmol/l DDT, 0.01 mmol/l EDTA, 5% (w/v) glycerol, 0.1% (w/v) Triton X-100, 0.2 mmol/l each dNTP, 1.0 to 2.0 mmol/l MgCl 2 and 0.5 mmol/l of each primer specific for each gene. The PCR primers were designed using Primer Premier 5.0 and were synthesised by Haojia Biotech. Ltd., China. The nucleotide sequences of these primers and the PCR conditions are shown in Table 1 . The Quantum RNA 18S Internal Standards kit (Catalogue no. 1716, Ambion Inc., Austin, TX, USA) containing primers and competitors was used to normalise variations in pipetting and amplification.
Different controls were set to monitor the possible contaminations of genomic DNA and environment DNA both at the stage of RT and RCR. The pooled samples made by mixing equal quantity of total RNA from all samples were used for optimising the PCR condition and normalising the intra-assay variations. All samples were included in the same run of RT-PCR and repeated at least for three times.
Quantitation of PCR products and statistical analysis An aliquot of PCR products was analysed by electrophoresis on 2% agarose (for muscle growth-related genes) or 8.0% PAGE (for MyHC isoforms) gels. The gels were stained with ethidium bromide and photographed with digital camera. The net intensities of individual bands were measured using Yang, Chen, Xu and Zhao Kodak Digital Science 1D software (Eastman Kodak Company Rochester, NY, USA). Expression of each isoforms of MyHCs was estimated as the relative value of MyHC 1, 2a or 2b to MyHC 2x ( Table 2 ). The mRNA expression of other muscle growth-related genes was normalised to 18S rRNA.
The results were expressed as mean 6 s.e. Data were analysed using the general linear model procedure (Statistical Packages for the Social Sciences, 2001) and the model included the rpGH treatment, muscle and rpGH treatment 3 muscle interaction. Differences were considered significant when P , 0.05.
Results
Body weight gain and myofibre composition of LD and ST muscles The initial and final body weights of pigs were 50.5 6 1.3 kg and 71.5 6 1.8 kg in the rpGH treatment group and 51.2 6 1.6 kg and 67.8 6 1.8 kg in the control group, respectively. Administration of rpGH significantly increased the average daily weight gain by 26.1% (749.6 6 31.5 g v. 594.6 6 17.3 g, P , 0.05).
Relative to MyHC 2x, MyHC 2b was expressed more abundantly in LD muscle than in ST muscle, whereas the opposite was true for MyHC 1. In general, rpGH administration had no effect on myofibre-type composition in either LD or ST muscle (Table 2) . mRNA expression of growth-related genes in LD and ST muscle The abundances of 18S rRNA showed no difference between LD and ST muscles, and were not altered by rpGH treatment (data not shown). No significant rpGH treatment 3 muscle interaction was found for any of the indices evaluated.
Among all the growth-related genes examined in the present experiment, only calpain 3 exhibited significant muscle effect. LD muscle showed significantly higher abundance of calpain 3 mRNA than in with ST muscle in general (P , 0.001), as shown in Figure 5 .
No significant treatment effect was seen in the abundances of myostatin and myogenin mRNA irrespective of muscle types (Figures 2 and 3) .
Both MyoD and calpain 3 displayed significant treatment effect irrespective of muscle types. However, the up-regulation of MyoD and calpain 3 mRNA expression responding to rpGH reached the level of statistical significance (P , 0.05) in ST but not in LD muscle when the treatment effects were analysed in each type of muscle, respectively (Figures 4 and 5) . In addition, a tendency of down-regulation for the mRNA expression of PGC-1a was seen in ST muscle of rpGH-treated group (P 5 0.16, Figure 6 ). 
Discussion
In the present study, the myofibre-type distribution was not affected by rpGH administration in both LD and ST muscle, as detected with molecular-typing technique developed recently and applied elsewhere (Tanabe et al., 1999; Zhao et al., 2004) . This is in agreement with previous findings obtained by using histochemical staining (Solomon et al., 1988 and 1990; Beermann et al., 1990; Ono et al., 1995; Sorensen et al., 1996) and by directly measuring the mRNA and protein levels of MyHC isoforms (Czerwinski and Martin, 1994) . However, there have been some controversial results reported by Solomon et al. (1991) who found that at the body weight of 60 and 90 kg, LD muscle of pigs injected with 100 mg/kg per day pGH from 30 to 60 kg possessed of more oxidative-glycolytic fibres and fewer glycolytic fibres. Later, it is reported that pGH-affected muscle fibre-type composition in a muscle type-specific pattern. ST muscle in pGH-treated pigs (100 mg/kg per day for 42 days) had more oxidative-glycolytic fibres and fewer glycolytic fibres at 30 kg of body weight, whereas this change was not observed in longissimus, semimembranosus and triceps muscle of the same pigs (Solomon et al., 1994) . The reasons for such discrepancy concerning the effect of rpGH on myofibre types are complex, which involve the age or the body weight when the animals started to receive the rpGH treatment, the length of the treatment, the doses, the routes of administration, the nutritional and physiological status (including genders) of the animals, as well as the muscle types and sensitivity and specificity of the methods used for myofibre typing.
Compared with the inconsistent effect of rpGH on myofibre types, the effect of rpGH on myofibre hypertrophy was observed in nearly all the published studies. Our previous finding of increased expression of GHR and IGF-1 mRNA in ST muscle upon GH administration would explain partly the mechanism of rpGH on myofibre hypertrophy . However, the responses of candidate downstream genes, such as myostatin, myogenin, myoD, etc. following the activation of GHR and IGF-1, have not been clarified.
Myostatin knockout mice deposit two-to three-fold greater muscle mass than their wild-type littermates due to increase in both muscle fibre number (hyperplasia) and the fibre cross-sectional area (hypotrophy) (McPherron et al., 1997) during embryonic and early postnatal development (Wehling et al., 2000; Whittemore et al., 2003) . A disruption of myostatin function by transgenic expression of its propetide (the 5 0 region, 866 nucleotides) was reported to result in significant muscle growth (Yang et al., 2001) . Nevertheless, the expression of myostatin mRNA did not seem to be influenced by rpGH administration in growing pigs (Ji et al., 1998) , which is supported by our result that shows no significant difference in myostatin mRNA abundance between control and rpGH-treated pigs. These results results of statistical analysis. No significant muscle effect or rpGH treatment 3 muscle interaction was seen for myoD mRNA expression. A significant rpGH treatment effect (P , 0.05) was observed irrespective of muscle types. *Indicates significant difference between control and treated group when the differences were compared in LD and ST muscle, respectively (P , 0.05). No significant rpGH treatment3 muscle interaction was seen for calpain 3 mRNA expression. Significant muscle effect (P , 0.001) and rpGH treatment effect (P , 0.05) were observed. * indicates significant difference between control and treated group when the differences were compared in LD and ST muscle, respectively (P , 0.05). hint that myostatin may not be involved in the pathway that mediates the effect of rpGH on muscle growth in pigs.
Myogenin and myoD both belong to the MRF family, but with different functions. MyoD is required for commitment of myoblasts during early myogenic process, whereas myogenin plays a pivotal role in the terminal differentiation of myofibres. Myogenin knockout mice can survive foetal development but die immediately after birth with a severe reduction of all skeletal muscles (Hasty et al., 1993) . During myogenesis, the stimulation of differentiation by IGF-I is (at least in part) a result of substantially increased levels of the mRNA for myogenin (Florini et al., 1996) . However, no information is available whether the expression of myoD and myogenin is influenced in rpGH-treated pigs. Our finding is that myogenin expression was unaffected while myoD mRNA expression was up-regulated especially in the ST muscle after rpGH administration. This may indicate that myogenin plays a specific role in early myogenesis or is not involved in the action of rpGH in pigs. Hughes et al. (1993 and reported a dramatic increase in myoD expression in the soleus muscle of rats after thyroid hormone treatment. Hence, myoD is not only responsible for myoblast commitment during embryonic myogenesis, but also participates in the satellite cell recruitment during fast growth induced by rpGH in postnatal life of pigs.
The muscle type-specific expression of myoD and myogenin has been addressed previously in some publications. Hughes et al. (1993) demonstrated that myoD selectively accumulative in the white muscle while myogenin is selectively accumulative in the red muscle in adult rats. But in cattle, Muroya et al. (2002) reported no significant difference in myogenin mRNA abundance among slow and fast muscles. Te Pas et al. (2000) noted that myogenin and myoD expression in different muscles were inconsistent in selection for leanness and selection for porcine growth rate. In our study, these two genes did not show selective expression patterns between the two types of muscle, which partly agrees with Te Pas et al. (2000) concerning the fast-growing pigs.
Calpain 3, as a skeletal muscle-specific protease, participates in the regulation of myogenesis in cultured C2C12 cell lines via its action on certain proteins belonging to the myogenic regulator factor (Dargelos et al., 2002) . Mutations in the calpain 3 have been shown to be responsible for limb-girdle muscular dystrophy type 2A (Sorimachi et al., 1995) . Jones et al. (1999) demonstrated that calpain 3 was present in all fibres of pigs but at a significantly lower level in slow type I compared with fast type IIA/IIB fibres, as observed in the present study. In the stopped growth caused by feeding a protein-free diet, van den HemelGrooten et al. (1997) demonstrated that the calpain 3 mRNA expression in LD muscle of pigs was significantly decreased. In the present study, calpain 3 expression increased upon rpGH administration. Moreover, the upregulation of calpain 3 expression was more remarkable in ST than in LD, demonstrating the muscle type-specific responses of this gene to rpGH treatment. However, Ji et al. (1998b) stated that calpain 3 showed no response to 3 mg/ day pGH injection in the longssimus muscle of barrow with the initial body weight of 64.2 to 67.4 kg. This difference may be due to the methods used to detect the calpain 3 mRNA expression; the RT-PCR used in the present study is more sensitive than the ribonuclease protection assay used in Ji's study.
To our knowledge, this is the first report describing the effect of exogenous GH on the expression of PGC-1a in domestic animals. Lin et al. (2002) demonstrated that PGC1a was expressed preferentially in muscle enriched in type I fibres and drove the formation of the oxidative muscle fibre type (slow twitch) in transgenic mice. After prolonged lowintensity physical exercises, PGC-1a expression was increased both in rats (Goto et al., 2000; Baar et al., 2002; Terada and Tabata, 2004; Taylor et al., 2005) and in humans (Russell et al., 2003) , accompanied with the increased percentage of oxidative fibres. We found in our previous study that PGC-1a mRNA abundance was significantly higher in LD muscle of Erhualian pigs (a Chinese indigenous breed) which possess more oxidative fibres (MyHC 1 and MyHC 2a) compared with Large White pigs (Zhao et al., 2004) . In this context, the tendency of down-regulated PGC-1a expression in ST muscle of treated pigs would indicate more anaerobic metabolisms although no significant alterations were detected for myofibre types. The small proportion of slow myofibre in LD muscle may be attributed to the irresponsiveness of PGC-1a mRNA expression to rpGH treatment, as observed in the present experiment.
In conclusion, myoD, calpain 3 and probably PGC-1a may be involved in the pathway that mediates the action of rpGH skeletal muscle growth. rpGH up-regulates mRNA expression of myoD and calpain 3 in a muscle type-specific manner, being more remarkable in oxidative fibre-enriched muscles.
